The stock price of MediWound Ltd (NASDAQ: MDWD) has jumped by 14.25 compared to previous close of 16.00. Despite this, the company has seen a gain of 14.90% in its stock price over the last five trading days. Zacks Investment Research reported 2024-03-25 that The mean of analysts’ price targets for MediWound (MDWD) points to a 76.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Is It Worth Investing in MediWound Ltd (NASDAQ: MDWD) Right Now?
Moreover, the 36-month beta value for MDWD is 0.88. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MDWD is 6.81M and currently, short sellers hold a 2.39% of that float. On April 17, 2024, MDWD’s average trading volume was 67.31K shares.
MDWD’s Market Performance
The stock of MediWound Ltd (MDWD) has seen a 14.90% increase in the past week, with a 14.25% rise in the past month, and a 42.04% gain in the past quarter. The volatility ratio for the week is 8.31%, and the volatility levels for the past 30 days are at 6.37% for MDWD. The simple moving average for the past 20 days is 18.96% for MDWD’s stock, with a 68.62% simple moving average for the past 200 days.
Analysts’ Opinion of MDWD
Many brokerage firms have already submitted their reports for MDWD stocks, with Maxim Group repeating the rating for MDWD by listing it as a “Buy.” The predicted price for MDWD in the upcoming period, according to Maxim Group is $11 based on the research report published on December 22, 2022 of the previous year 2022.
Oppenheimer, on the other hand, stated in their research note that they expect to see MDWD reach a price target of $7. The rating they have provided for MDWD stocks is “Outperform” according to the report published on July 18th, 2022.
BTIG Research gave a rating of “Buy” to MDWD, setting the target price at $6 in the report published on September 23rd of the previous year.
MDWD Trading at 25.88% from the 50-Day Moving Average
After a stumble in the market that brought MDWD to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 5.97% of gains for the given period.
Volatility was left at 6.37%, however, over the last 30 days, the volatility rate increased by 8.31%, as shares surge +16.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +48.38% upper at present.
During the last 5 trading sessions, MDWD rose by +14.90%, which changed the moving average for the period of 200-days by +80.99% in comparison to the 20-day moving average, which settled at $15.49. In addition, MediWound Ltd saw 79.74% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for MDWD
Current profitability levels for the company are sitting at:
- -0.82 for the present operating margin
- 0.19 for the gross margin
The net margin for MediWound Ltd stands at -0.36. The total capital return value is set at -0.27. Equity return is now at value -31.60, with -11.53 for asset returns.
Based on MediWound Ltd (MDWD), the company’s capital structure generated 0.18 points at debt to capital in total, while cash flow to debt ratio is standing at -1.44. The debt to equity ratio resting at 0.21. The interest coverage ratio of the stock is -70.4.
Currently, EBITDA for the company is -14.2 million with net debt to EBITDA at 0.38. When we switch over and look at the enterprise to sales, we see a ratio of 9.0. The receivables turnover for the company is 4.23for trailing twelve months and the total asset turnover is 0.28. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.59.
Conclusion
To wrap up, the performance of MediWound Ltd (MDWD) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
